InvestSMART

PharmAust Limited (ASX: PAA) - Announcements

Current share price for PAA : $0.230 0.015 (6.98%)+

ASX company news and announcements for PharmAust Limited (PAA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All PharmAust Limited (PAA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than PharmAust Limited (PAA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for PharmAust Limited (PAA)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
- SPP Shortfall Heaily Oversubscribed 1 Oct 2013 12:28PM $0.011 $0.230 risen by 1,990.91%
- Appendix 4E & Full Year Statutory Accounts 30 Aug 2013 1:44PM $0.009 $0.230 risen by 2,455.56%
- Appendix 4C 31 Jul 2013 6:14PM $0.012 $0.230 risen by 1,816.67%
- PharmAust Fully Executes Share Sale Agreement With Pitney 23 Jul 2013 10:49AM $0.010 $0.230 risen by 2,200%
- Appendix 4C - quarterly 30 Apr 2013 4:09PM $0.013 $0.230 risen by 1,669.23%
- PharmAust to acquire rights to 3 oncology product platforms 30 Apr 2013 11:49AM $0.013 $0.230 risen by 1,669.23%
- Trading Halt 29 Apr 2013 3:55PM $0.009 $0.230 risen by 2,455.56%
- Appendix 4D and Financial Report Dec 2012 18 Feb 2013 4:30PM $0.009 $0.230 risen by 2,455.56%
- Appendix 4C - quarterly 18 Jan 2013 8:27AM $0.012 $0.230 risen by 1,816.67%
- Appendix 4C - quarterly 31 Oct 2012 6:09PM $0.008 $0.230 risen by 2,775%
- Share Sale Deed executed for the sale of Pela Resources 10 Sep 2012 12:08PM $0.010 $0.230 risen by 2,200%
- Appendix 4E / Full Year Statutory Accounts 30 Aug 2012 6:16PM $0.012 $0.230 risen by 1,816.67%
- Placement & Offer to Purchase Pela Resources 31 Jul 2012 2:21PM $0.012 $0.230 risen by 1,816.67%
- Appendix 4C - quarterly 30 Apr 2012 5:44PM $0.010 $0.230 risen by 2,200%
- Appendix 4C - quarterly 30 Apr 2012 5:44PM $0.010 $0.230 risen by 2,200%
- Appendix 4D / Half Year Financial Report 29 Feb 2012 7:16PM $0.014 $0.230 risen by 1,542.86%
- Appendix 4C - Quarterly Report and Brief Company Update 31 Jan 2012 7:22PM $0.016 $0.230 risen by 1,337.50%
- Epichem Gains 51% Interest in JV for New Diabetes Treatment 28 Nov 2011 12:34PM $0.019 $0.230 risen by 1,110.53%
- Trading Halt 24 Nov 2011 7:54PM $0.016 $0.230 risen by 1,337.50%
- Appendix 4C - quarterly 28 Oct 2011 3:28PM $0.020 $0.230 risen by 1,050%
- Luke River Project - Antimony Target 19 Oct 2011 12:05PM $0.022 $0.230 risen by 945.45%
- Clarification on Record Date for SPP 6 Oct 2011 6:32PM $0.020 $0.230 risen by 1,050%
- Appendix 4E / Full Year Statutory Accounts 31 Aug 2011 8:23AM $0.018 $0.230 risen by 1,177.78%
- Luke River Project - Exploration Update 30 Aug 2011 12:42PM $0.023 $0.230 risen by 900%
- Appendix 4C - quarterly 1 Aug 2011 8:31AM $0.025 $0.230 risen by 820%

651 - 675 of 796 results

Page 27 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.